Clinical profile and therapeutic strategies in patients with arrhythmogenic cardiomyopathy treated in a national reference institute
Authors:
- Rocio Huerta RoblesRRRocio Huerta Robles
- Jorge Francisco Chávez SolsolJSJorge Francisco Chávez Solsol
- Juan Manuel Muñoz MorenoJMJuan Manuel Muñoz Moreno
- Mario Raul Cabrera SaldañaMSMario Raul Cabrera Saldaña
- Zoila Rodríguez UrteagaZUZoila Rodríguez Urteaga
- Marco Gutierrez GaribayMGMarco Gutierrez Garibay
Open Access
- 11 March 2021
- journal article
- research article
- Published by Instituto Nacional Cardovascular - Carlos Alberto Peschiera Carrillo in Archivos Peruanos de Cardiología y Cirugía Cardiovascular
- Vol. 2 (1) , 3-14
Abstract
Objective. To determine the epidemiological, clinical, electrocardiographic, imaging characteristics and main therapeutic strategies performed in patients with arrhythmogenic cardiomyopathy treated in a national reference cardiovascular institute. Materials and methods. Observational, descriptive and retrospective study that attempts to identify the clinical characteristics, complementary tests and therapeutic strategies performed in patients with arrhythmogenic cardiomyopathy treated at the National Cardiovascular Institute - INCOR EsSalud in Lima, Peru. Results. Thirteen patients were found with arrhythmogenic cardiomyopathy. The median age at which the diagnosis was made was 38.2 years and 69.3% of those affected were male. The most frequent clinical manifestations were tachycardic palpitations (92.3%), presyncope (84.6%) and heart failure (69.2%). 23% of the patients suffered a cardiac arrest. All the patients presented at least one episode of ventricular tachycardia, 92.3% with complete left bundle branch block morphology and upper axis. 76.9% received an implantable cardioverter defibrillator (ICD), 15.3% underwent ablation and 15.3% received a heart transplant. 84.6% of the patients live to this day. Conclusions. Arrhythmogenic cardiomyopathy predominantly affected the young and male population. All the patients had a potentially fatal ventricular arrhythmia. Biventricular disease by echocardiography and cardiac magnetic resonance occurred in 69.2% and 100% of the cases, respectively. The therapeutic strategies used were antiarrhythmic medical treatment, placement of an ICD as secondary prevention, ablation, and heart transplantation. To date, 84.6% of patients survive.Keywords
This publication has 29 references indexed in Scilit:
- Arrhythmogenic Right Ventricular Dysplasia/CardiomyopathyCirculation, 2011
- ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 Appropriate Use Criteria for Cardiac Computed TomographyJACC, 2010
- Prophylactic Implantable Defibrillator in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia and No Prior Ventricular Fibrillation or Sustained Ventricular TachycardiaCirculation, 2010
- Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/DysplasiaCirculation, 2010
- Electrocardiographic Features of Arrhythmogenic Right Ventricular DysplasiaCirculation, 2009
- Left-Dominant Arrhythmogenic CardiomyopathyJACC, 2008
- Quantitative assessment of endomyocardial biopsy in arrhythmogenic right ventricular cardiomyopathy/dysplasia: an in vitro validation of diagnostic criteriaEuropean Heart Journal, 2008
- Clinical and Genetic Characterization of Families With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Provides Novel Insights Into Patterns of Disease ExpressionCirculation, 2007
- Arrhythmogenic Right Ventricular Cardiomyopathy/DysplasiaCirculation, 2006
- Adipositas cordis, fatty infiltration of the right ventricle, and arrhythmogenic right ventricular cardiomyopathy. Just a matter of fat?Cardiovascular Pathology, 2005